drugset / Trial / NCT00525057
Dalteparin in Preventing DVT in Participants With Cancer
NaSingle-groupOpen-labelPrevention
Summary
This trial studies how well dalteparin works in preventing deep vein thrombosis (DVT) (blood clots) in participants with cancer. Dalteparin is a blood thinner that can treat blood clots and may prevent them from forming.
Timeline
- Start
- 2006-07-07
- Primary completion
- 2020-06-19
- Completion
- 2020-06-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalteparin sodium | Other / unclassified | — | Subcutaneous |